CONTEXT THERAPEUTICS INC's ticker is and the CUSIP is 21077P108. A total of 24 filers reported holding CONTEXT THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $55,805 | +184.6% | 34,878 | 0.0% | 0.15% | +1030.8% |
| Q1 2023 | $19,608 | -13.7% | 34,878 | 0.0% | 0.01% | -27.8% |
| Q4 2022 | $22,730 | -41.7% | 34,878 | 0.0% | 0.02% | -10.0% |
| Q3 2022 | $39,000 | -47.3% | 34,878 | 0.0% | 0.02% | -52.4% |
| Q2 2022 | $74,000 | – | 34,878 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 1,165,100 | $2,528,000 | 0.38% |
| Worth Venture Partners, LLC | 317,729 | $689,000 | 0.32% |
| Affinity Asset Advisors, LLC | 777,610 | $1,687,000 | 0.27% |
| Knoll Capital Management, LLC | 139,520 | $303,000 | 0.19% |
| swisspartners Ltd. | 42,235 | $92,000 | 0.07% |
| Veritable, L.P. | 110,249 | $239,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 49,912 | $108,000 | 0.00% |
| MORGAN STANLEY | 10,000 | $22,000 | 0.00% |
| BlackRock Inc. | 16,961 | $37,000 | 0.00% |
| Citadel Advisors | 18,516 | $40,000 | 0.00% |